How to Buy Aurinia Pharmaceuticals Stock
Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc. , a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally.
Aurinia Pharmaceuticals stock last closed at $4.91, up 0.82% from the previous day, and has decreased 56.04% in one year. It has underperformed other stocks in the Biotechnology industry by 0.34 percentage points. Aurinia Pharmaceuticals stock is currently +4.25% from its 52-week low of $4.71, and -60.5% from its 52-week high of $12.43.
At the moment, there are 144.62M shares of AUPH outstanding. The market capitalization of AUPH is $710.07M. In the last 24 hours, 985,127 AUPH shares were traded.
How to Buy Aurinia Pharmaceuticals Stock
Wondering how to invest in Aurinia Pharmaceuticals stock? Here's how.
- Figure out where to buy Aurinia Pharmaceuticals stock: You need to choose a stock brokerage, but don't worry - we've tested dozens of online brokerages and apps to help you choose where to buy Aurinia Pharmaceuticals stock.
- Create your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
- Fund your brokerage account: Select your payment method and add your info.
- Analyze Aurinia Pharmaceuticals stock: The Aurinia Pharmaceuticals ticker symbol is AUPH. Is Aurinia Pharmaceuticals stock a good investment? Should you buy shares of AUPH? How do AUPH's underlying business fundamentals look? Do top analysts think Aurinia Pharmaceuticals is a good buy? Why has AUPH's stock price moved recently? (Hint: Our stock analysis website can help you understand if AUPH is a good stock to buy).
- Place your AUPH purchase: Decide if you will purchase AUPH shares at the current market price or use a limit order to purchase AUPH stock at a specific price.
- Keep tabs on your investment in AUPH: Create a watchlist to important notifications about your new investment in Aurinia Pharmaceuticals shares.
Step 1: Figure out where to buy Aurinia Pharmaceuticals stock
You need an online brokerage account to access the NASDAQ market and buy AUPH shares.
Our favorite brokerage: eToro
We believe that eToro is the best place to buy stocks. eToro gives you:
- Invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
- Access to world financial markets: From Technology to Utilities, New York to Tokyo — you can fill your portfolio with stocks from the globe's top exchanges.
- Social investing: eToro offers a community of more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptos.
Get $10 towards your purchase of stock by signing up for an account with eToro now.
Open eToro AccountStep 2: Create your brokerage account
Now that you've selected your brokerage, the next step is to fill out some personal details so you can invest in AUPH today.
How to Start a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal data to create a new trading account.
- Submit your application by hitting the "Create Account" button. Get started with eToro today
Step 3: Fund your brokerage account
Now that you have opened your account on the best stock app, you need to deposit funds:
Check out the tutorial below to see the process of transferring money into your new investment account.
Step 4: Analyze Aurinia Pharmaceuticals stock
After you have figured out the best place to buy Aurinia Pharmaceuticals stock, it's very important to research their stock before you buy, so you can comprehend the risk as well as the opportunity.
Aurinia Pharmaceuticals quick stats
AUPH Zen Score
WallStreetZen was built to help everyday investors do more in-depth fundamental analysis in minutes instead of hours.
You can view all of the due diligence checks on AUPH's stock page.
How is AUPH stock valued?
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge AUPH's fair value.
Using relative valuations measures:
- AUPH may be undervalued based on its P/B ratio of 1.88x, relative to Biotechnology industry P/B ratio of 5.85x
You can do more valuation analysis on AUPH's stock here.
Is AUPH a healthy company?
Positive Financial Indicators:
- There are more short-term assets than long-term liabilities on the AUPH balance sheet.
- AUPH has $350.49M in cash and short term investments. This is sufficient to cover its annual cash burn of $34.18M.
- There are more short-term assets than short-term liabilities on the AUPH balance sheet.
- AUPH has cash burn of 34179000. It has sufficient cash and short-term investments to cover this for at least one year.
Negative Financial Indicators:
- AUPH has a relatively high debt to equity ratio of 0.45.
- Total AUPH debt is higher than 5 years ago, relative to shareholder equity.
- AUPH profit margin has gone up by 0.36 percentage points in the past year, but the company is still unprofitable.
Is it a good time to buy AUPH stock, according to analysts?
Out of 3 Equities analysts who give ratings on AUPH, the consensus analyst rating on Aurinia Pharmaceuticals is a Strong Buy
Please keep in mind that analyst ratings are not recommendations, nor are they investment advice.
You can dive deeper into what analysts are forecasting on the Aurinia Pharmaceuticals stock forecast page.
Metrics for Advanced AUPH Traders
AUPH Performance Metrics
Last year, AUPH revenue was $175.51M. Over the last 5 year, AUPH's revenue has gone up by 227.9% per year. This was faster than the Biotechnology industry average of 28.56%.
You can analyze AUPH's earnings and revenue performance here.
Latest Insiders Trades at AUPH
In the past 12 months, insiders at AUPH have sold more shares than they have bought.
Matthew Maxwell Donley, EVP Ops Strategy of AUPH, was the latest AUPH insider to sell. They sold $224,064.15 worth of AUPH stock on Mar 6, 2024.
Get more info about who owns AUPH shares here.
Can I rely on AUPH as an income stream?
No, Aurinia Pharmaceuticals doesn't provide an income stream by paying out dividends.
Get analysis from other traders
One of the reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to learn what other investors have to say.
Step 5: Place your AUPH purchase
You have two main types of orders:
- Market order: A market order is an order to buy or sell a stock at the best price on the market.
Market orders are mostly the easiest way to buy. - Limit order: A limit order is an order to buy or sell a stock at a specific price (or better).
If you want to be certain you're buying or selling at a given price, place a limit order.
Hit the Open Trade button and your broker will place your order.
If you require more assistance investing in stocks on eToro, watch the helpful video below:
Step 6: Keep tabs on your investment in AUPH
Now that you own some shares in AUPH, you'll want to stay up-to-date on your new investment.
Add AUPH to a watchlist to get notified of the latest news about your AUPH stock.
AUPH Feed
How to Buy Stock in Aurinia Pharmaceuticals
To reiterate, here are the 6 steps for buying Aurinia Pharmaceuticals stock:
- Figure out where to buy Aurinia Pharmaceuticals stock
- Create your brokerage account
- Fund your brokerage account
- Analyze Aurinia Pharmaceuticals stock
- Place your AUPH purchase
- Keep tabs on your investment in AUPH
If you need a brokerage, eToro is our recommended option.
Get Started with eToro TodayIf you would like to get the latest scoop on your new investment in Aurinia Pharmaceuticals, create a watchlist today.
Other Content You May Like
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.